BCDA BioCardia Inc.

2.76
+0.03  (+1%)
Previous Close 2.73
Open 2.87
Price To Book 3.63
Market Cap 18,837,505
Shares 6,825,183
Volume 8,496
Short Ratio
Av. Daily Volume 5,454
Stock charts supplied by TradingView

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 3 DSMB review to be released March 31, 2020.
CardiAMP (BCDA-01)
Heart Failure
Phase 3 trial to be initiated 2Q 2020.
CardiAMP (BCDA-02)
Chronic Myocardial Ischemia